Virtus ETF Advisers’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Virtus ETF Advisers’s Portfolio PRNB Stock Details PRNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-5,775	Closed	-$345K	–	446
2020 Q2	$345K	Sell	5,775 -1,460	-20%	-$90.2K	0.16%	269
2020 Q1	$430K	Sell	7,235 -1,042	-13%	-$60.7K	0.18%	188
2019 Q4	$453K	Buy	8,277 +983	+13%	+$36.7K	0.07%	217
2019 Q3	$206K	Sell	7,294 -406	-5%	-$14.9K	0.04%	247
2019 Q2	$256K	Sell	7,700 -1,348	-15%	-$42.1K	0.05%	268
2019 Q1	$308K	Sell	9,048 -1,260	-12%	-$40.1K	0.66%	58
2018 Q4	$282K	Buy	+10,308	New	+$266K	0.05%	134

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return

Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ADL

Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Virtus ETF Advisers's PRNB Position: Q3 2020 in Review

Virtus ETF Advisers sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 5,775 shares — an estimated $345K sold.

Virtus ETF Advisers first reported a position in PRNB in Q4 2018 and held it in 7 quarters. The position peaked at $453K in Q4 2019. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

Virtus ETF Advisers reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Virtus ETF Advisers sold 5,775 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $345K.
Virtus ETF Advisers first reported a position in Principia Biopharma Inc. Common Stock in Q4 2018 and held it in 7 quarters.
Virtus ETF Advisers's Principia Biopharma Inc. Common Stock position peaked at $453K in Q4 2019.
9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Virtus ETF Advisers's 13F filing for Q3 2020, filed 13 Nov 2020.